Imunon, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-14.5M | $-18.6M | $-19.5M | $-35.9M | $-20.8M | $-21.5M | $-16.9M | $-11.9M |
| Depreciation & Amortization | — | $240.0K | $248.0K | $731.6K | $702.9K | $741.5K | $721.7K | $356.9K |
| Depreciation | $291.9K | $240.2K | $248.2K | $196.5K | $130.0K | $130.0K | $128.5K | $130.0K |
| Amortization | — | — | — | — | — | — | — | $227.3K |
| Stock-Based Compensation | $127.4K | $477.3K | $759.0K | $2.7M | $3.8M | $1.9M | $2.3M | $4.6M |
| Net Cash from Operating Activities | $-13.9M | $-18.9M | $-19.0M | $-23.1M | $-16.2M | $-15.6M | $-20.3M | $-7.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $280.6K | $29.5K | $451.8K | $267.8K | $311.6K | $19.1K | $349.2K | $138.4K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-280.6K | $9.8M | $11.0M | $8.3M | $-30.1M | $7.9M | $5.9M | $-1.6M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $17.1M | $9.1M | $-3.6M | $6.7M | $54.8M | $18.0M | $7.8M | $10.6M |
| Net Change in Cash | $2.9M | $34.2K | $-11.7M | $-8.1M | $8.4M | $10.3M | $-6.5M | $1.9M |
| Free Cash Flow | $-14.2M | $-18.9M | $-19.5M | $-23.4M | $-16.5M | $-15.6M | $-20.6M | $-7.2M |